Manifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoAvviso sulla qualità dei datiDati della fonte degradati
Dati al 26 ott 2026, 04:02 UTC · criterio pm-quality-4
Previsione della comunità attualeNo 85.7%
Previsori
18
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato 2 ore fa
Obsoleto3 ago 23, 18:56 UTC2 gen 28, 07:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will Jumping Heel Click advance past the Emoji Subcommittee's first review stage?
Manifold MarketsIsrael x Hamas Ceasefire Phase II by which date?
PolymarketIsrael x Hamas Ceasefire Phase II by which date?
FutuurSkin cancer vaccine BLA submitted by which date?
PolymarketIs Cheryl Scott from ABC CHICAGO pregnant????!?!??? 🤰
Manifold MarketsAnthropic lab leak by which date?
PolymarketRegole
Recently the small molecule drug AOH1996 has recieved some attention on social media for its potential to treat a variety of cancers with basically no side effects in animal models.
- Here is a good overview: https://www.science.org/content/blog-post/new-mode-cancer-treatment
- The question here is whether this drug will succeed in Phase II trials.
- Unlike the ongoing Phase I trials, which are designed to show safety, Phase II trails must show efficacy.
- Success can unambiguously be defined as either FDA approval (under an accelerated approval process, which this drug may get) or advancing to Phase III trails.
- (Note that in Phase III trials a drug is evaluated for comparative efficacy against other treatment options).
